8-K filing — Pluri Inc. (PLUR)
Filed: 2026-08-28 AccNo: 0001213900-26-094638 Size: 809 KB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 9.01: Financial Statements and Exhibits
Stocks · News reference
Pluri Announces Chairman Alejandro Weinstein Has Invested $17M+In PLUR, Including A $1.25M Advance Investment Made In June 2026
His growing commitment comes as Pluri advances its transition from platform development toward commercial execution, with an increasing focus on longevity and planned commercial activity in the United States. Alongside
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Pluri Commences ~$3.3M Offering Of 2.229M Common Shares At $1.50 Per Share
Pluri Inc. (NASDAQ:PLUR) (TASE: PLUR) ("Pluri"), a biotechnology company, leveraging its proprietary three-dimensional ("3D") cell expansion platform across two principal business verticals: (i) Human
Pluri Subsidiary Ever After Foods Announces Acquisition Of Belgian Cultivated Fish Company Fishway, Secures Additional $2M Strategic Investment
Pluri Unit Cellav Health And Aesthetics Completes Cosmetic Regulatory Registration And Notification In The UK, Supporting Commercial Launch Of Regenativo+
The regulatory registration enables Cellav to commercially market its product in the UK and represents an important step in the Company's broader strategy to establish a global presence in the fast-growing